Literature DB >> 20425408

The host-tumor interface in B-cell non-Hodgkin lymphoma: a new world to investigate.

Nicolas Rachinel1, Gilles Salles.   

Abstract

Research on B-cell non-Hodgkin lymphoma focuses mainly on oncogenic events occurring in lymphoma cells, but recently a new component has appeared that may be crucial in lymphomagenesis: the tumor microenvironment. Indeed, compelling evidence demonstrates the key role played by nonmalignant bystander cells in the establishment and proliferation of the tumor. Among these cells, stromal cells, monocytes/macrophages, and T cells in lymphoid organs have all been described as contributing to tumor progression. Interactions linked to cell-cell intimate contacts-but also mediated through soluble mediators such as cytokines and chemokines-do form a specific network. All these interrelations directed by the tumor create a friendly environment for lymphoma cells that permits them to proliferate. Blocking the cross-talk between the tumor microenvironment and lymphoma cells may thus represent a promising new strategy for treating B-cell malignancies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20425408     DOI: 10.1007/s11899-009-0026-1

Source DB:  PubMed          Journal:  Curr Hematol Malig Rep        ISSN: 1558-8211            Impact factor:   3.952


  43 in total

1.  Kinetics and signaling requirements of CD40-mediated protection from B cell receptor-induced apoptosis.

Authors:  Jonna Eeva; Ville Postila; Mikko Mättö; Ulla Nuutinen; Antti Ropponen; Mine Eray; Jukka Pelkonen
Journal:  Eur J Immunol       Date:  2003-10       Impact factor: 5.532

2.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

3.  Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling.

Authors:  Richard J Byers; Ebrahim Sakhinia; Preethi Joseph; Caroline Glennie; Judith A Hoyland; Lia P Menasce; John A Radford; Timothy Illidge
Journal:  Blood       Date:  2008-01-03       Impact factor: 22.113

4.  Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL).

Authors:  Pedro Farinha; Hamid Masoudi; Brian F Skinnider; Karey Shumansky; John J Spinelli; Karamjit Gill; Richard Klasa; Nicolas Voss; Joseph M Connors; Randy D Gascoyne
Journal:  Blood       Date:  2005-06-02       Impact factor: 22.113

5.  Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis.

Authors:  J Plumas; M C Jacob; L Chaperot; J P Molens; J J Sotto; J C Bensa
Journal:  Blood       Date:  1998-04-15       Impact factor: 22.113

6.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

7.  Dendritic reticulum cell pattern as a microenvironmental indicator for a distinct origin of lymphoma of follicular mantle cells.

Authors:  R Manconi; A Poletti; R Volpe; S Sulfaro; A Carbone
Journal:  Br J Haematol       Date:  1988-02       Impact factor: 6.998

8.  Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma.

Authors:  Sajjan Mittal; Neil A Marshall; Linda Duncan; Dominic J Culligan; Robert N Barker; Mark A Vickers
Journal:  Blood       Date:  2008-02-27       Impact factor: 22.113

9.  Splenic T zone development is B cell dependent.

Authors:  V N Ngo; R J Cornall; J G Cyster
Journal:  J Exp Med       Date:  2001-12-03       Impact factor: 14.307

10.  Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis.

Authors:  Cornelia Hömig-Hölzel; Caroline Hojer; Julia Rastelli; Stefano Casola; Lothar J Strobl; Werner Müller; Leticia Quintanilla-Martinez; Andreas Gewies; Jürgen Ruland; Klaus Rajewsky; Ursula Zimber-Strobl
Journal:  J Exp Med       Date:  2008-05-19       Impact factor: 14.307

View more
  4 in total

1.  Tumor fragmentation estimated by volume surface ratio of tumors measured on 18F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphoma.

Authors:  Pierre Decazes; Stéphanie Becker; Mathieu Nessim Toledano; Pierre Vera; Paul Desbordes; Fabrice Jardin; Hervé Tilly; Isabelle Gardin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-28       Impact factor: 9.236

2.  Nuclear Factor kappa B is central to Marek's disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo.

Authors:  Shyamesh Kumar; Dusan Kunec; Joram J Buza; Hsin-I Chiang; Huaijun Zhou; Sugalesini Subramaniam; Ken Pendarvis; Hans H Cheng; Shane C Burgess
Journal:  BMC Syst Biol       Date:  2012-09-14

3.  Immune independent crosstalk between lymphoma and myeloid suppressor CD14+HLA-DRlow/neg monocytes mediates chemotherapy resistance.

Authors:  Zhe Jenny Zhang; Peggy A Bulur; Ahmet Dogan; Dennis A Gastineau; Allan B Dietz; Yi Lin
Journal:  Oncoimmunology       Date:  2015-01-26       Impact factor: 8.110

Review 4.  Cell-Free DNA for the Management of Classical Hodgkin Lymphoma.

Authors:  Vincent Camus; Fabrice Jardin
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.